Study of UCB8600 on gut mast cells in IBS and colorectal cancer
Part of Digestive system clinical trials.
This study looks at how a medicine called UCB8600 affects certain immune cells (mast cells) in the gut. It is for people having colorectal cancer surgery and for patients with irritable bowel syndrome (IBS). The goal is to understand how the medicine works in the body and if it can help with IBS symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having surgery for colorectal cancer and have not had chemotherapy or radiation before surgery.
- You are 18 or older (if in the surgery group) or between 18 and 65 years old (if in the IBS group).
- Your body mass index (BMI) is under 30 (not obese).
- You are not taking certain allergy medicines (antihistamines) at the time of surgery or biopsy.
- You are not taking blood thinners (for IBS group only).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a tiny capsule to collect samples from your small intestine to learn about gut bacteria in people with IBS or other functional gut disorders. It could help researchers understand what causes digestive symptoms.
This study checks how sensitive your gut is to normal stimuli in people with IBS, ulcerative colitis, Crohn’s disease, and in healthy volunteers. Results may help researchers understand why some people feel more abdominal discomfort and how that connects to inflammatory bowel conditions.
This study is gathering information from people with active Crohn's disease or ulcerative colitis, and from people without IBD. Researchers will look at samples from the colon to learn more about these conditions.
This study follows adults with Crohn’s disease or ulcerative colitis when their treatment is changed. It collects health information and samples to better understand how treatment changes affect people over time.
This study follows people with Crohn's disease or ulcerative colitis (and healthy volunteers) to understand what affects the disease's progression and complications. It looks at factors like your gut bacteria and immune treatments.
This study looks at how gut bacteria and immune activity differ in normal, pre-cancer, and cancer colon tissue. It may help researchers understand what changes in the body are linked to colon growth and how they could be targeted in the future.
Hear when a new IBS (Irritable Bowel Syndrome) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.